Washington, September 29 : Scientists researching male contraceptives have devised various new techniques that may provide men with an alternative to vasectomy in about half a decade.
The researchers presented their findings from experiments on mice and men at the second ‘Future of Male Contraception’ conference, held from 27 to 28 September in Seattle, Washington.
Los Angeles: The Food and Drug Administration had sanctioned a new version of a ringworm drug to treat tinea capitis, a scalp fungus for children aged 4 years and older.
Tinea capitis is an unrelenting and infectious fungal infection, which generally does not respond to topical treatment. It can result in severe itchiness, dandruff and bald patches.
A recent study has discovered that thimerosal, a mercury-containing chemical compound that is used in vaccines and immune globulin formulations, does not have an effect on neuropsychological functioning in kids aged between 7 to 10.
According to a DeCA news release, the Defense Commissary Agency has called back a few of its frozen ground beef products accompanying a U.S. Department of Agriculture notice of possible E. coli contamination.
The group carries two of the recalled products prepared by Topps Meat Company LLC:
Washington, Sept 28 : A new study has found that there is no difference in the risk of developing breast cancer between wine, beer or spirits, since it is the consumption of alcohol itself and the quantity that triggers the cancer.
The study found that the increased breast cancer risk from drinking three or more alcoholic drinks a day is similar to the increased breast cancer risk from smoking a packet of cigarettes or more a day.
Washington, Sept 28 : A new research has revealed that pregnancy does not harm chances of survival from cancer.
The study by Norwegian scientists has found that for almost all types of cancer, the survival of women who are diagnosed during pregnancy or who became pregnant after being treated for the disease is no different from that of other female cancer patients.
Los Angeles: The Food and Drug Administration had sanctioned a new version of a ringworm drug to treat tinea capitis, a scalp fungus for children aged 4 years and older. 
